Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This update reports a completed Phase 1/Phase 2 trial of a monoclonal antibody therapy in patients with leukemia, sponsored by the National Cancer Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Radiation Toxicity | Phase 1, Phase 2 | Status: COMPLETED